About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

3 Medical Technology Stocks Outperforming in 2025

Top-Performing MedTech Stocks in 2025 - This image is an original composition by MarketBeat using licensed and editorial elements. Not for redistribution or reuse.

As the broader market stages a sharp rebound from its April lows, several sectors, industries, and stocks have quietly emerged as leaders. Among them, the medical technology industry, known for its innovation and growth potential, has stood out. Several mid- and large-cap medical technology names have broken out of their bases, surged past key levels, and demonstrated strong earnings momentum.

Here are three medical technology stocks that are not only outperforming the broader market but are also building compelling bullish setups for the months ahead.

TransMedics Group: A Mid-Cap Medical Technology Powerhouse

[content-module:Forecast|NASDAQ: TMDX]

TransMedics Group (NASDAQ: TMDX), a commercial-stage med-tech company transforming organ transplant therapy, has been one of the year’s most impressive comeback stories. After a difficult 2024, shares of TMDX have roared back in 2025, up over 100% year-to-date and 92% this quarter alone.

A standout earnings report on May 8 fueled the breakout rally. TransMedics posted Q1 EPS of $0.70, crushing consensus estimates of $0.29 by $0.41. Revenue surged 48.2% year-over-year to $143.5 million, exceeding expectations.

From a technical standpoint, the stock is basing above key support near $120 and its 20-day moving average. While short interest is elevated, nearly 25% of the float is sold short, it could provide fuel for a continued rally if momentum persists. Analysts remain bullish, with a consensus rating of Moderate Buy. However, it’s worth noting that institutional inflows over the previous twelve months have been net negative, along with the consensus price target among analysts implying slight downside.

Insulet Corporation: Nearing All-Time Highs

[content-module:Forecast|NASDAQ: PODD]

Insulet (NASDAQ: PODD), a member of the S&P 500, specializes in insulin delivery systems for patients with insulin-dependent diabetes. The company has quietly become one of the strongest performers in the medical devices space, with shares up more than 22% YTD and now trading just below all-time highs.

Insulet’s recent run was sparked by its May 8 earnings report, where Q1 EPS came in at $1.02, beating estimates by $0.21. Revenue grew 28.8% year-over-year to $569 million, topping analyst forecasts.

The stock surged from $260 to $310 immediately following the report and has since been consolidating just under key resistance near $327. A breakout above that level could put the all-time high of $336 in play. Analyst sentiment is overwhelmingly positive, with 14 out of 17 analysts rating the stock a Buy. In total, the stock has a consensus rating of Moderate Buy.

Insulet’s strong fundamentals, technical setup, and leadership within the sector make it a name to watch closely as we head into the summer.

GRAIL: A High-Risk, High-Reward Contender

[content-module:Forecast|NASDAQ: GRAL]

GRAIL (NASDAQ: GRAL), a mid-cap company focused on early cancer detection through advanced machine learning and diagnostics, has surged 124% YTD. While its fundamental performance trails the other names on this list, the stock is showing strong momentum and interest from speculative investors.

The company reported Q1 earnings on May 13, posting an EPS of negative $3.10, which was better than the expected negative $4.03, but still showed significant losses. Revenue for the quarter came in at $31.84 million, missing estimates of $35.80 million. Despite the weaker report, the stock has held up well and is consolidating within a bullish wedge pattern, with $45 as key resistance.

As with TMDX, GRAIL carries significant short interest, around 21% of the float, which could lead to a short squeeze if the stock breaks out. While the valuation and path to profitability remain concerns, the strong technical momentum, short interest, and upside potential make this a speculative name worth monitoring.

Where Should You Invest $1,000 Right Now?

Before you make your next trade, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.

Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.

They believe these five stocks are the five best companies for investors to buy now...

See The Five Stocks Here

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.03
+5.55 (2.56%)
AAPL  262.77
+0.53 (0.20%)
AMD  238.03
-2.53 (-1.05%)
BAC  51.52
-0.52 (-1.00%)
GOOG  251.34
-5.68 (-2.21%)
META  733.27
+1.10 (0.15%)
MSFT  517.66
+0.87 (0.17%)
NVDA  181.16
-1.48 (-0.81%)
ORCL  275.15
-2.03 (-0.73%)
TSLA  442.60
-4.83 (-1.08%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.